Actively Recruiting
Comparing Ultrasound-Guided Nerve Blocks for Pain Relief and Breathing Safety in Shoulder Surgery
Led by Ankara Etlik City Hospital · Updated on 2026-08-07
70
Participants Needed
1
Research Sites
2 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying pain management methods for patients undergoing shoulder surgery, a common orthopedic procedure often linked with moderate to severe pain after surgery. The study compares two nerve block techniques the standard interscalene brachial plexus block, which can cause breathing difficulties due to unintended nerve effects, and a newer diaphragm-sparing method combining suprascapular and axillary nerve blocks. The goal is to assess pain relief and preserve respiratory function during recovery. Participants will receive one of two ultrasound-guided nerve block procedures before surgery. One group will have an interscalene block with 10 mL of 0.5% bupivacaine injected near the C5 and C6 nerve roots. The other group will receive a combination of suprascapular and axillary nerve blocks, each with 5 mL of 0.5% bupivacaine injected around specific nerves near the shoulder. Both procedures are designed to provide pain relief while minimizing breathing complications. During the study, participants pain intensity at rest and movement will be measured up to 24 hours after surgery, along with total opioid consumption. Respiratory function will be monitored by measuring diaphragmatic movement and lung volumes before and after the nerve blocks and throughout the perioperative period. The study includes adult patients aged 18 to 65 scheduled for elective arthroscopic shoulder surgery, with assessments focused on pain control and breathing safety.
CONDITIONS
Brief Title
Anterior Suprascapular and Axillary vs. Interscalene Block for Analgesia and Diaphragmatic Function in Shoulder Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged between 18 and 65 years
- American Society of Anesthesiologists (ASA) physical status I, II, or III
- Patients scheduled to undergo elective arthroscopic shoulder surgery
- Body mass index (BMI) between 18 and 30 kg/m2
- Ability to provide written informed consent
You will not qualify if you...
- Known allergy or hypersensitivity to local anesthetics
- Localized infection at the planned injection site
- Severe coagulopathy or active use of anticoagulant medications
- Contralateral phrenic nerve palsy or diagnosis of severe chronic obstructive pulmonary disease (COPD)
- History of chronic opioid consumption or neuropathic pain
Research Team
İ
İbrahim Topcu
M
Musa Zengin
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here